Navigation Links
BioReliance Corporation Launches iNet(TM) for Online Results Tracking of Biological Safety Tests
Date:9/18/2007

ROCKVILLE, Md., Sept. 18 /PRNewswire/ -- BioReliance Corporation, a leading contract services organization for the biopharmaceutical and pharmaceutical industries, announced today the launch of iNet, a proprietary information technology system that enables customers to submit test article details via controlled and secure Internet access from any location worldwide. In real-time, BioReliance clients can now view the status of current and past studies, keep informed of expected completion dates, download reports, and allow colleagues to view testing status-all in one online environment.

BioReliance developed iNet to simplify test article submissions and to promote instantaneous communications between clients and internal project managers. "As a result of these efforts," stated Tim Derrington, President and CEO of BioReliance, "our customers are now armed with a web-enabled application that offers a precise picture of their project's current and future status. We look forward to greatly expanding our iNet user base in the upcoming months and continuing to develop and integrate new technologies that will enhance our customers' service experiences with BioReliance."

Pavel Khrimian, Senior Project Manager, commented, "The response from our early-access iNet users has been very positive. Customers are using the projected lab initiation and report completion dates to facilitate their project planning efforts. In addition, the electronic template used for sample submission has simplified their paperwork, while making the entire process more timely and manageable."

Judith Apshago, Senior Director of Global IT, also added, "A lot of effort was placed into making iNet user-friendly, secure and compliant. As a result, preliminary users have navigated through the submission process with little difficulty. In addition, we have implemented multiple layers of security both on the front end and the back end to create an extremely secure online environment that validates users and ensures data integrity."

iNet is compliant with 21 CFR Part 11 for user authentication, and data exchange over the web is protected by use of Secured Sockets Layer certificates procured from VeriSign(R). It is also compatible with both Windows and Mac operating systems.

The iNet application is available to US biologics testing customers upon request. This service will be available at a future date for studies conducted in the UK, as well as for viral clearance and toxicology clients.

About BioReliance

BioReliance Corporation is a leading contract services organization, offering more than 1,000 tests or services related to biologics safety testing, in vitro and in vivo toxicology, viral manufacturing and lab animal health diagnostics for the biopharmaceutical and pharmaceutical industries. The Company provides cost-effective services to over 600 clients annually, including most of the largest pharmaceutical and biopharmaceutical companies in the world. BioReliance is headquartered in Rockville, Maryland and has additional facilities in Glasgow, Scotland and Stirling, Scotland. For more information, visit http://www.bioreliance.com.

Contact

Cindy Goldstein

Director, Global Marketing

BioReliance Corporation

cindy.goldstein@bioreliance.com

+1 301.610.2544


'/>"/>
SOURCE BioReliance Corporation
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Trouble-shooting: Misincorporation or low fidelity
2. Roche Diagnostics Corporation
3. Roche Diagnostics Corporation
4. Promega Corporation: Wisconsins quiet innovator
5. Giuliani will keynote RedPrairie Corporations user conference
6. Madison Development Corporation makes loans to three area companies
7. Corporations and blogging
8. Metavante acquires Florida banking corporation
9. TriMas Corporations Cequent Group Acquires Chem-Chrome, Inc.
10. Merge launches diagnostic mammography workstation in Europe
11. Einstein Wireless launches cellular alert system
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/12/2019)... ... November 12, 2019 , ... Peggy Lillis Foundation (PLF) has ... healthcare-associated infection C. diff. The campaign, “See C. diff,” combines basic ... least 30,000 people in the U.S. each year. The campaign also features a ...
(Date:11/6/2019)... ... November 06, 2019 , ... ... off-the-record collaboration and dialogue, today announces its East/West CEO conference to ... San Francisco. , Kicking off the week of the J.P. Morgan ...
(Date:11/5/2019)... (PRWEB) , ... November 05, 2019 , ... Ole, a German Shepherd, was demonstrating signs ... stairs and jumping. Though his energy level and his willingness to play were normal, ... surgeon Dr. Holly Mullen of VCA Emergency Animal Hospital and Referral Center in ...
(Date:11/2/2019)... ... October 31, 2019 , ... drug360 graph, a breakthrough knowledge ... drug360 brings tellic’s expertise in biomedical language processing and machine learning to bear ... between genes, diseases, variants, phenotypes, and other biomedical entities. Researchers and analysts ...
Breaking Biology Technology:
(Date:11/6/2019)... ... 2019 , ... In October, Massachusetts stem cell biotechnology company ... a poorly disclosed deficiency in stem cell treatments. Throughout stem cell medical ... stem cells. This problem affects all patients receiving stem cell treatments, including ...
(Date:11/5/2019)... , ... November 05, 2019 , ... ... Dentistry, providing state-of-the-art cosmetic and restorative dentistry to Seattle, WA, including porcelain ... of Dental Surgery degree from the University of Washington, Dr. Kopp is passionate ...
(Date:10/30/2019)... ... October 29, 2019 , ... ... kits, for SIEMENS ATELLICA® analyzers, Order Numbers 701sa & 704sa. The kits, in ... UA, UTP, and UUN. , Each VALIDATE® kit, liquid, ready-to-use, and prepared using ...
Breaking Biology News(10 mins):